Evidence map›Paper›PMID 41030187›Full record

ArticleAngewandte Chemie (International ed. in English)2025

Adaptive Rhodium Catalysis with a Lewis‑Acidic Secondary Sphere for Divergent Hydrogenation of Propargylic Alcohols.

Jiajun Wu, Vishal Chugh, Lachlan Sharp-Bucknall, Ibrahim Abdellah, Alexandre Vasseur, Christophe Werlé

Abstract read
In one paragraph

Article in Angewandte Chemie (International ed. in English), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jiajun WuMax Planck Institute for Chemical Energy Conversion, Stiftstr. 34-36, 45470, Mülheim an der Ruhr, Germany.ORCID https://orcid.org/0000-0002-9588-7331
Vishal ChughMax Planck Institute for Chemical Energy Conversion, Stiftstr. 34-36, 45470, Mülheim an der Ruhr, Germany.ORCID https://orcid.org/0000-0002-3875-4962
Lachlan Sharp-BucknallMax Planck Institute for Chemical Energy Conversion, Stiftstr. 34-36, 45470, Mülheim an der Ruhr, Germany.ORCID https://orcid.org/0000-0002-4728-7964
Ibrahim AbdellahUniversité de Lorraine, CNRS, L2CM, Metz, F-57000, France.ORCID https://orcid.org/0000-0002-0060-7211
Alexandre VasseurUniversité de Lorraine, CNRS, L2CM, Nancy, F-54000, France.ORCID https://orcid.org/0000-0003-3294-2417
Christophe WerléMax Planck Institute for Chemical Energy Conversion, Stiftstr. 34-36, 45470, Mülheim an der Ruhr, Germany.ORCID https://orcid.org/0000-0002-2174-2148

Funding

Deutsche ForschungsgemeinschaftFrench National Research Agency (ANR)Fuel Science Center 90919832Germany's Excellence Strategy-Exzellenzcluster 2186Lorraine Université d'Excellence ANR-15-IDEX-04-LUE
6 · The paper itself

Abstract

Achieving chemoselective transformations of multifunctional molecules under mild and sustainable conditions remains a central challenge in catalysis. Here, we show that a rhodium complex equipped with a Lewis acidic secondary coordination sphere can mediate condition-dependent, divergent hydrogenation of propargylic alcohols. By tuning the reaction medium, the system selectively yields one of three products-retained alkynes, allylic ethers, or (E)-alkenes-from a single substrate-catalyst pair under hydrogen. Mechanistic studies implicate π-allyl and rhodium hydride intermediates, with solvent polarity and nucleophilicity steering the reaction pathway. Control experiments confirm the critical roles of both molecular hydrogen and the boron Lewis acid in enabling divergent selectivity. These findings demonstrate how rational secondary-sphere design can enable adaptive catalysis and provide a platform for programmable bond transformations in multifunctional substrates.

Indexed as

Adaptive catalysisDivergent hydrogenationPropargylic alcoholsRhodiumSecondary‐sphere interactions

Identifiers

PMID41030187
PMCPMC12668305

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.